Dendritic Cell-derived Extracellular Vesicles mediate Mesenchymal Stem/Stromal Cell recruitment

Scientific Reports

Volumn 7, Issue 1, 2017, Pages

  Silva, Andreia M ^a,b,c   Almeida, Maria I ^a,b   Teixeira, José H ^a,b,c   Maia, André F ^a,d   Calin, George A ^e   Barbosa, Mário A ^a,b,c   Santos, Susana G ^a,b  

^a UNIVERSITY OF PORTO   (Portugal)

^b INEB INSTITUTO DE ENGENHARIA BIOMÉDICA   (Portugal)

^c UNIVERSITY OF PORTO   (Portugal)

^d UNIVERSITY OF PORTO   (Portugal)

^e UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CULTURE; CELL DIFFERENTIATION; CELL MOTION; CELL PROLIFERATION; DENDRITIC CELL; ENDOCYTOSIS; EXOSOME; HUMAN; MESENCHYMAL STEM CELL; METABOLISM; ULTRASTRUCTURE;

CELL DIFFERENTIATION; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; DENDRITIC CELLS; ENDOCYTOSIS; EXOSOMES; EXTRACELLULAR VESICLES; HUMANS; MESENCHYMAL STEM CELLS;

EID: 85019240385     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-017-01809-xh     Document Type: Article

References (54)

1. Claes, L., Recknagel, S. & Ignatius, A. Fracture healing under healthy and inflammatory conditions. Nat. Rev. Rheumatol. 8, 133-143, doi:10.1038/nrrheum.2012.1 (2012).
2. Gerstenfeld, L. C. et al. Impaired fracture healing in the absence of TNF-alpha signaling: the role of TNF-alpha in endochondral cartilage resorption. J. Bone Miner. Res. 18, 1584-1592, doi:10.1359/jbmr.2003.18.9.1584 (2003).
3. Crotti, T. N. et al. Osteoimmunology: Major and Costimulatory Pathway Expression Associated with Chronic Inflammatory Induced Bone Loss, Osteoimmunology: Major and Costimulatory Pathway Expression Associated with Chronic Inflammatory Induced Bone Loss. J. Immunol. Res. 2015(1-13), e281287, doi:10.1155/2015/281287 (2015).
4. György, B. et al. Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles. Cell. Mol. Life Sci. 68, 2667-2688, doi:10.1007/s00018-011-0689-3 (2011).
5. Stoorvogel, W., Kleijmeer, M. J., Geuze, H. J. & Raposo, G. The biogenesis and functions of exosomes. Traffic 3, 321-330, doi:10.1034/j.1600-0854.2002.30502.x (2002).
6. Rana, S., Yue, S., Stadel, D. & Zöller, M. Toward tailored exosomes: the exosomal tetraspanin web contributes to target cell selection. Int. J. Biochem. Cell Biol. 44, 1574-1584, doi:10.1016/j.biocel.2012.06.018 (2012).
7. Wiklander, O. P. B. et al. Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targeting. J. Extracell. Vesicles 4, 26316, doi:10.3402/jev.v4.26316 (2015).
8. Pant, S., Hilton, H. & Burczynski, M. E. The multifaceted exosome: biogenesis, role in normal and aberrant cellular function, and frontiers for pharmacological and biomarker opportunities. Biochem. Pharmacol. 83, 1484-1494, doi:10.1016/j.bcp.2011.12.037 (2012).
9. Yáñez-Mó, M. et al. Biological properties of extracellular vesicles and their physiological functions. J. Extracell. Vesicles 4, 27066, doi:10.3402/jev.v4.27066 (2015).
10. Fais, S. et al. Evidence-Based Clinical Use of Nanoscale Extracellular Vesicles in Nanomedicine. ACS Nano 10, 3886-3899, doi:10.1021/acsnano.5b08015 (2016).
11. Tkach, M. & Théry, C. Communication by Extracellular Vesicles: Where We Are and Where We Need to Go. Cell 164, 1226-1232, doi:10.1016/j.cell.2016.01.043 (2016).
12. Esser, J. et al. Exosomes from human macrophages and dendritic cells contain enzymes for leukotriene biosynthesis and promote granulocyte migration. J. Allergy Clin. Immunol. 126, 1032-1040, doi:10.1016/j.jaci.2010.06.039 (2010).
13. Zhao, Q., Ren, H. & Han, Z. Mesenchymal stem cells: Immunomodulatory capability and clinical potential in immune diseases. J. Cell. Immunother. 2, 3-20, doi:10.1016/j.jocit.2014.12.001 (2016).
14. Silva, A. M. et al. Extracellular Vesicles: Immunomodulatory messengers in the context of tissue repair/regeneration. Eur. J. Pharm. Sci. 98, 86-95, doi:10.1016/j.ejps.2016.09.017 (2016).
15. DiMarino, A. M., Caplan, A. I. & Bonfield, T. L. Mesenchymal Stem Cells in Tissue Repair. Front. Immunol. 4, article 201, doi:10.3389/fimmu.2013.00201 (2013).
16. Rustad, K. C. & Gurtner, G. C. Mesenchymal Stem Cells Home to Sites of Injury and Inflammation. Adv. Wound Care 1, 147-152, doi:10.1089/wound.2011.0314 (2012).
17. Silva, A. M. et al. Resveratrol as a Natural Anti-Tumor Necrosis Factor-Molecule: Implications to Dendritic Cells and Their Crosstalk with Mesenchymal Stromal Cells. PLoS ONE 9, e91406, doi:10.1371/journal.pone.0091406 (2014).
18. Almeida, C. R., Vasconcelos, D. P., Gonçalves, R. M. & Barbosa, M. A. Enhanced mesenchymal stromal cell recruitment via natural killer cells by incorporation of inflammatory signals in biomaterials. J. R. Soc. Interface 9, 261-271, doi:10.1098/rsif.2011.0357 (2012).
19. Ekström, K. et al. Monocyte Exosomes Stimulate the Osteogenic Gene Expression of Mesenchymal Stem Cells. PLoS ONE 8, e75227, doi:10.1371/journal.pone.0075227 (2013).
20. Loi, F. et al. Inflammation, fracture and bone repair. Bone 86, 119-130, doi:10.1016/j.bone.2016.02.020 (2016).
21. Lötvall, J. et al. Minimal experimental requirements for definition of extracellular vesicles and their functions: a position statement from the International Society for Extracellular Vesicles. J. Extracell. Vesicles 3, 26913, doi:10.3402/jev.v3.26913 (2014).
22. Kowal, J. et al. Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes. Proc. Natl. Acad. Sci. USA 113, E968-977, doi:10.1073/pnas.1521230113 (2016).
23. Raposo, G. & Stoorvogel, W. Extracellular vesicles: Exosomes, microvesicles, and friends. J. Cell Biol. 200, 373-383, doi:10.1083/jcb.201211138 (2013).
24. Torreggiani, E. et al. Exosomes: novel effectors of human platelet lysate activity. Eur. Cell. Mater. 28, 137-151, doi:10.22203/eCM (2014).
25. Nakamura, Y. et al. Mesenchymal-stem-cell-derived exosomes accelerate skeletal muscle regeneration. FEBS Lett. 589, 1257-1265, doi:10.1016/j.febslet.2015.03.031 (2015).
26. Furuta, T. et al. Mesenchymal Stem Cell-Derived Exosomes Promote Fracture Healing in a Mouse Model. Stem Cells Transl. Med. sctm. 5, 2015-0285, doi:10.5966/sctm.2015-0285 (2016).
27. Qin, Y., Wang, L., Gao, Z., Chen, G. & Zhang, C. Bone marrow stromal/stem cell-derived extracellular vesicles regulate osteoblast activity and differentiation in vitro and promote bone regeneration in vivo. Sci. Rep. 6, 21961, doi:10.1038/srep21961 (2016).
28. Qi, X. et al. Exosomes Secreted by Human-Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells Repair Critical-Sized Bone Defects through Enhanced Angiogenesis and Osteogenesis in Osteoporotic Rats. Int. J. Biol. Sci. 12, 836-849, doi:10.7150/ijbs.14809 (2016).
29. Martins, M., Ribeiro, D., Martins, A., Reis, R. L. & Neves, N. M. Extracellular Vesicles Derived from Osteogenically Induced Human Bone Marrow Mesenchymal Stem Cells Can Modulate Lineage Commitment. Stem Cell Rep. 6, 284-291, doi:10.1016/j. stemcr.2016.01.001 (2016).
30. Sun, W. et al. Osteoclast-derived microRNA-containing exosomes selectively inhibit osteoblast activity. Cell Discov. 2, 16015, doi:10.1038/celldisc.2016.15 (2016).
31. Zhang, J. et al. Exosomes/tricalcium phosphate combination scaffolds can enhance bone regeneration by activating the PI3K/Akt signaling pathway. Stem Cell Res. Ther. 7, doi:10.1186/s13287-016-0391-3 (2016).
32. Swaney, K. F., Huang, C.-H. & Devreotes, P. N. Eukaryotic Chemotaxis: A Network of Signaling Pathways Controls Motility, Directional Sensing, and Polarity. Annu. Rev. Biophys. 39, 265-289, doi:10.1146/annurev.biophys.093008.131228 (2010).
33. Pepperell, E. E. & Watt, S. M. A novel application for a 3-dimensional timelapse assay that distinguishes chemotactic from chemokinetic responses of hematopoietic CD133+stem/progenitor cells. Stem Cell Res. 11, 707-720, doi:10.1016/j.scr.2013.04.006 (2013).
34. Yoon, D. et al. Study on chemotaxis and chemokinesis of bone marrow-derived mesenchymal stem cells in hydrogel-based 3D microfluidic devices. Biomater. Res. 20, doi:10.1186/s40824-016-0070-6 (2016).
35. Sung, B. H., Ketova, T., Hoshino, D., Zijlstra, A. & Weaver, A. M. Directional cell movement through tissues is controlled by exosome secretion. Nat. Commun. 6, 7164, doi:10.1038/ncomms8164 (2015).
36. Wang, Z. et al. Engineered mesenchymal stem cells with enhanced tropism and paracrine secretion of cytokines and growth factors to treat traumatic brain injury. Stem Cells 33, 456-467, doi:10.1002/stem.1878 (2015).
37. Raheja, L. F., Genetos, D. C. & Yellowley, C. E. Hypoxic osteocytes recruit human MSCs through an OPN/CD44-mediated pathway. Biochem. Biophys. Res. Commun. 366, 1061-1066, doi:10.1016/j.bbrc.2007.12.076 (2008).
38. Zou, C., Song, G., Luo, Q., Yuan, L. & Yang, L. Mesenchymal stem cells require integrin 1 for directed migration induced by osteopontin in vitro. Vitro Cell. Dev. Biol.-Anim. 47, 241-250, doi:10.1007/s11626-010-9377-0 (2010).
39. Zohar, R., Cheifetz, S., McCulloch, C. A. & Sodek, J. Analysis of intracellular osteopontin as a marker of osteoblastic cell differentiation and mesenchymal cell migration. Eur. J. Oral Sci. 106(Suppl 1), 401-407, doi:10.1111/eos.1998.106.issue-S1 (1998).
40. Suzuki, K. et al. Colocalization of intracellular osteopontin with CD44 is associated with migration, cell fusion, and resorption in osteoclasts. J. Bone Miner. Res. Off. J. Am. Soc. Bone Miner. Res. 17, 1486-1497, doi:10.1359/jbmr.2002.17.8.1486 (2002).
41. Zhu, B. et al. Osteopontin modulates CD44-dependent chemotaxis of peritoneal macrophages through G-protein-coupled receptors: evidence of a role for an intracellular form of osteopontin. J. Cell. Physiol. 198, 155-167, doi:10.1002/jcp.10394 (2004).
42. Dwyer, R. M. et al. Monocyte Chemotactic Protein-1 Secreted by Primary Breast Tumors Stimulates Migration of Mesenchymal Stem Cells. Clin. Cancer Res. 13, 5020-5027, doi:10.1158/1078-0432.CCR-07-0731 (2007).
43. Ringe, J. et al. Towards in situ tissue repair: Human mesenchymal stem cells express chemokine receptors CXCR1, CXCR2 and CCR2, and migrate upon stimulation with CXCL8 but not CCL2. J. Cell. Biochem. 101, 135-146, doi:10.1002/jcb.21172 (2007).
44. Belema-Bedada, F., Uchida, S., Martire, A., Kostin, S. & Braun, T. Efficient homing of multipotent adult mesenchymal stem cells depends on FROUNT-mediated clustering of CCR2. Cell Stem Cell 2, 566-575, doi:10.1016/j.stem.2008.03.003 (2008).
45. Ponte, A. L. et al. The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities. Stem Cells 25, 1737-1745, doi:10.1634/stemcells.2007-0054 (2007).
46. Gonçalves, R. M., Antunes, J. C. & Barbosa, M. A. Mesenchymal stem cell recruitment by stromal derived factor-1-delivery systems based on chitosan/poly(-glutamic acid) polyelectrolyte complexes. Eur. Cell. Mater. 23, 249-260, doi:10.22203/eCM (2012).
47. Vandooren, J., Van den Steen, P. E. & Opdenakker, G. Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9): the next decade. Crit. Rev. Biochem. Mol. Biol. 48, 222-272, doi:10.3109/10409238.2013.770819 (2013).
48. Ries, C. et al. MMP-2, MT1-MMP, and TIMP-2 are essential for the invasive capacity of human mesenchymal stem cells: differential regulation by inflammatory cytokines. Blood 109, 4055-4063, doi:10.1182/blood-2006-10-051060 (2007).
49. Dalli, J. et al. Heterogeneity in neutrophil microparticles reveals distinct proteome and functional properties. Mol. Cell. Proteomics 12, 2205-2219, doi:10.1074/mcp.M113.028589 (2013).
50. Kim, H.-S. et al. Proteomic analysis of microvesicles derived from human mesenchymal stem cells. J. Proteome Res. 11, 839-849, doi:10.1021/pr200682z (2012).
51. Takafuji, V., Forgues, M., Unsworth, E., Goldsmith, P. & Wang, X. W. An osteopontin fragment is essential for tumor cell invasion in hepatocellular carcinoma. Oncogene 26, 6361-6371, doi:10.1038/sj.onc.1210463 (2007).
52. Dominici, M. et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8, 315-317, doi:10.1080/14653240600855905 (2006).
53. Oliveira, M. I., Santos, S. G., Oliveira, M. J., Torres, A. L. & Barbosa, M. A. Chitosan drives anti-inflammatory macrophage polarisation and pro-inflammatory dendritic cell stimulation. Eur. Cell. Mater. 24, 136-153, doi:10.22203/eCM.v024a10 (2012).
54. Schindelin, J. et al. Fiji: an open-source platform for biological-image analysis. Nat. Methods 9, 676-682, doi:10.1038/nmeth.2019 (2012).